The Jackson Laboratory

Past Presenters

Please Note:  The 2016 Program  details and speakers will be updated often so please check back periodically for updates.

Click on each presenter to read full biography

Rick Altinger
arrow

Rick Altinger

CEO, Glooko
close
-
Mr. Altinger serves as Glooko’s first CEO, and brings over 15 years of industry experience in healthcare information technologies. While an executive at Intuit Health, Mr. Altinger helped launch the healthcare division’s provider services and drove Intuit’s acquisition of Medfusion in 2010. He also spearheaded Intuit Health’s growth as the leading supplier of patient-provider communication and patient portal services. His technical knowledge and expertise is central to Glooko’s diabetes healthcare platform and its goal of allowing anyone to monitor blood glucose levels regardless of meter, pump, CGM or mobile device type
Bonnie Anderson
arrow

Bonnie Anderson

President and CEO, Veracyte
close
-
President and CEO of Veracyte, a molecular diagnostics company that is pioneering the field of molecular cytology. Her career spans nearly 30 years in regulated diagnostics and life science markets. Under Ms. Anderson’s leadership, the company has achieved significant commercialization milestones since its formation as Veracyte in 2008, becoming a public company in 2013. These include the launch of its first product, the Afirma® Thyroid FNA Analysis, which centers on a genomic test designed to resolve ambiguity in thyroid nodule diagnosis. Backed by multiple, peer-reviewed, published studies and included in leading medical guidelines, Afirma is changing how physicians evaluate thyroid nodules – helping thousands of patients avoid unnecessary surgery and reducing healthcare costs. In 2011, Veracyte was named to The Wall Street Journal’s “The Next Big Thing” list of the top 50 venture-backed companies and in 2013, the company was honored with FierceMedicalDevice’s “Fierce 15” award. Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter. She currently serves as a member of the Board of Trustees of Keck Graduate Institute of Applied Life Sciences. She graduated from Indiana University of Pennsylvania with a Bachelors of Science degree in Medical Technology. Ms. Anderson has received numerous awards during her career, including being named in 2013 as one of the “Best Bay Area Life Sciences CEOs” by the San Francisco Business Times.
Jean-François Beaulé
arrow

Jean-François Beaulé

Executive Vice President, UnitedHealth Group
close
-
As executive vice president, Health Plan Design and Innovation, Mr. Beaulé leads the strategy for health plan engagement and design for UnitedHealth Group. Mr. Beaulé joined the company in 2006 as chief actuary of National Accounts, and currently leads innovations in the areas of consumer decision making in health and behavioral economics. Most recently, he developed and launched a standardized health score to promote individual health ownership. Earlier positions included those with Towers Perrin in Montreal and Cigna. He holds a bachelor's degree in Actuarial Sciences from Laval University, Québec City and is a Fellow of the Society of Actuaries.
Stephen Bloch
arrow

Stephen Bloch

General Partner, Canaan Partners
close
-
Stephen Bloch is a general partner, Canaan Partners, and currently serves on the boards of companies in digital health, biopharma, medical devices and diagnostics. Previously, Mr. Bloch founded multiple start-ups, including Radiology Management Sciences, where he was CEO for six years. He helped start OmniSonics Medical Technologies and co-founded TeleRad. He was a Ewing Marion Kauffman Fellow. He obtained his A.B. from Dartmouth College, his M.A. in the history of science and public policy from Harvard, and his M.D. from the University of Rochester. He trained in medicine at Massachusetts General Hospital/Harvard Medical School and Lenox Hill Hospital/Cornell Medical School.
William C. Bonfield M.D., M.P.H.
arrow

William C. Bonfield M.D., M.P.H.

Chief Medical Officer, Optum Behavioral Solutions
close
-
Dr, Bonfield oversees the development of clinical strategy, including clinical vision. He supervises Quality Management, Consumer Affairs, and Clinical Policy and Training. Dr. Bonfield has 43 years of experience in health care, 24 years in clinical practice and provider administration and 19 years in managed care. Before coming to Optum, he served as Chief Medical Officer of the Maricopa County Regional Behavioral Health Authority, the largest Medicaid behavioral health carve out in the country. In this position, he managed the Medical Affairs Department, Pharmacy Department, Medical and Nursing Staff, and the Quality Management Department.Prior to this role, Dr. Bonfield held senior leadership positions in managed care organizations and mental healthcare facilities and delivery systems. He also maintained a private clinical and consulting practice and served as a management resource to health care providers focusing on program design, professional staff relations, physician recruitment, and quality improvement.
Peter Bowers, M.D.
arrow

Peter Bowers, M.D.

Senior Clinical Officer , Anthem Blue Cross and Blue Shield in Connecticut
close
-
Dr. Peter Bowers is responsible for clinical affairs at Anthem Blue Cross and Blue Shield in Connecticut. He is also responsible for development and execution of medical management, cost of quality care and clinical support for sales in the Connecticut marketplace. Additionally, he has served as Medical Director for Anthem National Accounts and Anthem’s Payment Innovation which created novel value-based models of care delivery and transformation. He joined Anthem Blue Cross and Blue Shield in 2006 from the faculty of the Yale University School of Medicine as a Pediatric Cardiologist where he was active in teaching, clinical practice and biomedical research. He directed the fellowship training program in pediatric cardiology and won the pediatric resident teaching award in addition to an active clinical practice in both the outpatient and inpatient settings. With continuous funding from the National Institute of Health and the Howard Hughes Medical Institute, he investigated embryonic cardiovascular development and identified genetic causes of SIDS and congenital heart disease. Widely published, he has received awards from the Society of Pediatric Research, the American Academy of Pediatrics, the American College of Cardiology and the American Heart Association. A native of Connecticut, Dr. Bowers is a cum laude graduate of Colby College and the University of Connecticut School of Medicine. His post graduate medical training in pediatrics is from the University of Rochester and his fellowship training in pediatric cardiology and human molecular genetics is from Yale University. He lives in Guilford, CT with his wife, an obstetrician/ gynecologist and two daughters.
Andrea Branch. Ph.D.
arrow

Andrea Branch. Ph.D.

Professor Medicine, Liver Diseases, Associate Professor Surgery, Icahn School of Medicine at Mount Sinai
close
-
Dr. Branch is a professor of Medicine at the Icahn School of Medicine at Mount Sinai. She received a B.S. from the University of Michigan (Ann Arbor), an M.S. from the University of California (Irvine), and a Ph.D. from The Rockefeller University (New York). She has advanced training in molecular virology and addictive diseases research. She directs a translational research laboratory and also conducts clinical trials. Her primary research focus is on hepatitis C virus (HCV) infection and other chronic disease conditions that have a major strong inflammatory component.
Simon Budman, Ph.D
arrow

Simon Budman, Ph.D

Founder & CEO, Inflexxion
close
-
Dr. Budman has lectured worldwide and is an expert on data driven health quality improvement. Over the past 15 years, he has worked in the areas of behavioral healthcare, substance abuse, pain medicine and prescription opioid abuse. He has authored over 100 articles and books on behavioral healthcare and substance abuse. He has also been on over 20 NIH grants. He recently has been focused on ways to organize social media data and use it to measure product safety and abuse. Inflexxion’s SaaS software solutions are used in behavioral health, substance abuse and pain care settings nationwide.
Siobhan Bulfin
arrow

Siobhan Bulfin

CEO, Melon Health
close
-
Ms. Bulfin has over 15 years’ experience in social marketing and behavior change, and five years’ experience in applied game design. Her passion lies in empowering people to take control of their health through patient engagement – leveraging peer support, tracking and personalized, contextual interventions. She founded Melon Health after her sister went through breast cancer and Ms. Bulfin saw what was missing. Her mission is to make health care, everywhere care.
Tim Davenport
arrow

Tim Davenport

CEO, Consumable Science
close
-
Mr. Davenport has been involved in innovative and disruptive healthcare companies for the past decade. He served as President of Revolution Health where he led the development of a broad range of innovative offerings of health content, tools and wellness solutions. Recently, Davenport was the CEO of Sermo, a disruptive startup that grew to be the #1 social network for doctors in the U.S. Previously, Davenport was CEO of several technology companies including Best Software where he lead their successful IPO. He has served on the boards or advised: Diagnotes (present), Serena Software, Scraplog, Softrax, Yobongo, Everest Software. He began his career as an economist, then moved into the software industry, taking on senior product management roles leading to his promotion to General Manager of a division of Lotus Software.Tim earned his M.B.A from Harvard Business School and B.A. from Harvard College in Economics. He was also quarterback of the Harvard Football team.
Peter DeVault
arrow

Peter DeVault

Vice President, Epic
close
-
Mr. DeVault came to Epic in the mid-‘90s with a background in science. During his tenure, he has implemented Epic’s Electronic Health Record System at some of the country’s largest healthcare organizations, helped design Epic’s oncology module, and championed the research missions and interoperability goals of all its customers. He has taken on many national leadership roles with organizations including HL7, CCHIT, the EHR Association, ONC’s Standards and Interoperability Framework, and the Sequoia Project. He studies trends in world health and social care and helps international organizations to be successful users of the EHR and learn from each other.
Anthony B. Evnin, Ph.D.
arrow

Anthony B. Evnin, Ph.D.

Partner, Venrock
close
-
Dr. Evnin is a partner at Venrock, a venture capital firm, and on the Board of Directors of AVEO Pharmaceuticals, Infinity Pharmaceuticals, Juno Therapeutics and Constellation Pharmaceuticals. He is a trustee of The Rockefeller University and The Jackson Laboratory; member of the Boards of Overseers and Managers of Memorial Sloan-Kettering Cancer Center and of the Board of Directors of the Albert and Mary Lasker Foundation; director of the New York Genome Center; and Trustee Emeritus of Princeton University. He received an A.B. in chemistry from Princeton University and a Ph.D. in chemistry from the Massachusetts Institute of Technology.
Seth Feuerstein, , M.D., J.D.
arrow

Seth Feuerstein, , M.D., J.D.

Chief Medical Officer and Chief Innovation Officer, Magellan Healthcare and Yale University School of Medicine Department of Psychiatry
close
-
Dr. Feuerstein is a psychiatrist, entrepreneur and technology executive responsible for driving technology innovation within Magellan’s computerized cognitive behavioral therapy platform and programs. This portfolio is the leading behavioral change and engagement software suite used by millions of individuals throughout the U.S., U.K. and other health systems. Awarded the TripleTree iAward for Connected Health in the area of “Clinical Effectiveness,” this software was developed by Feuerstein’s team at Cobalt Therapeutics, a company he started and where he served as CEO until the company was acquired by Magellan in 2014. He also uses information technology in community service areas and founded a non-profit called Little Wonder, which improves the daily experience of cancer patients in treatment and helps patients and their loved ones create meaningful, powerful experiences together. His program has won several awards and has rapidly expanded to now serve 20 cancer centers. He holds medical and law degrees from New York University and completed his clinical training in psychiatry at the Yale University School of Medicine in New Haven, Conn., where he is a member of the clinical faculty.
Jeffrey A. Flaks
arrow

Jeffrey A. Flaks

Jeffrey A. Flaks, Executive Vice President and Chief Operating Officer, Hartford HealthCare
close
-
Mr. Flaks is the executive vice president and COO of Hartford HealthCare (HHC) where he is responsible for the system’s $2.5 billion operating budget and oversees all HHC operations, including five acute hospitals, a large physician practice, and multiple other healthcare services across three regions within Connecticut. He has been with Hartford HealthCare for 10 years, serving in previous roles as the president and CEO of Hartford Hospital, HHC’s flagship tertiary care center; the executive vice president and COO of Hartford Hospital and the executive vice president and COO of MidState Medical Center. In these roles Mr. Flaks achieved significant improvements in financial and operating performance and in quality and safety. He is also credited with championing HHC’s operating model “How Hartford HealthCare Works” (H3W) and driving the system’s cultural transformation. Previously, he held executive positions at Saint Vincent Catholic Medical Centers of New York and also held health care management positions at Beth Isreal in New York and the Detroit Medical Center in Michigan. Mr. Flaks is active in numerous community and professional organizations, is widely published and has been an invited speaker at numerous national and international conferences. He is a graduate of George Washington University with a master’s degree in health services administration and he received his Bachelor of Science degree at Ithaca College.
Marcia Fournier, Ph.D.
arrow

Marcia Fournier, Ph.D.

CEO and Founder, BIOARRAY Therapeutics Inc
close
-
Personalized medicine is what inspired Dr. Fournier to start a biotech company, BIOARRAY Therapeutics Inc. in Connecticut. She has over 15 years of experience in oncology and brings practical and strategic experience in drug discovery, biomarker development and clinical diagnostics. Prior to BIOARRAY, Dr. Fournier held a principal scientist position at GlaxoSmithKline, Oncology Center of Excellence for Drug Discovery. Her work as a postdoctoral fellow at UC Berkeley and doctoral fellow at the Dana-Farber Cancer Institute led to seminal peer-reviewed publications on oncology biomarker discovery. She is trained in genetics with a bachelor’s from Federal University of Rio de Janeiro.
Mark Friedlander, M.D., M.B.A.
arrow

Mark Friedlander, M.D., M.B.A.

Chief Medical Officer, Aetna Behavioral Health
close
-
Dr. Friedlander joined Aetna in 2002 as medical director for Aetna Behavioral Health. He is currently responsible for external relationships, strategic direction, oversight of patient management processes, quality management and accreditation, evaluation of new behavioral health technologies, and design and implementation of case and disease management programs. Dr. Friedlander is board certified in both Adult and Child/Adolescent Psychiatry. He is a recognized clinical leader in the field of Intellectual Disability and Neuropsychiatry and has been recognized as a "Top Doc" by Philadelphia Magazine.
Matthew Gevaert, Ph.D.
arrow

Matthew Gevaert, Ph.D.

CEO and Co-Founder, KIYATEC
close
-
Dr. Gevaert is CEO and co-founder of KIYATEC Inc., a life sciences company in Greenville, S.C. Previously, he led the commercialization of Clemson University’s biomedical and biotechnology intellectual property portfolio. He has experience with Merck, 3M and Dow Chemical, and been published in Science and the journal of the U.S. National Academy of Engineering. He graduated from the University of Waterloo with a bachelor’s degree in Applied Chemistry. He also holds a master’s degree and doctorate in Bioengineering from Clemson. He is an adjunct professor in Clemson’s Department of Bioengineering and a lecturer in its M.B.A. in Entrepreneurship & Innovation.
Paul Grundy, MD, MPH, FACOEM, FACPM
arrow

Paul Grundy, MD, MPH, FACOEM, FACPM

Founding President of Patient Centered Primary Care Collaborative and Director of IBM Global Healthcare Transformation
close
-
Dr. Paul Grundy is is the Global Director of HealthcareTransformation IBM Corporation where he develops and executes strategies thatsupport IBM’s transformation initiatives in the healthcare industry. Dr. Grundy is aHealthcare Ambassador for the Nation of Denmark and adjunct professor at theUniversity of Utah Department of Family and Preventive Medicine. He is amember of national Academy of Science’s Institute of Medicine, director of theACGME the body responsible for accrediting graduate medical trainingprograms, and member national advisory board of the National Center forInterprofessional Practice & Education. , Mayo Clinic Center for ConnectedCare (C3). Dr. Grundy is the President of the Patient-Centered Primary CareCollaborative (PCPCC). The PCPCC is a broad based coalition building PatientCenter Medical Home level care. He is a retired senior diplomat with the rank ofMinister Consular U.S. State Department.
Jill Hagenkord, MD, FCAP
arrow

Jill Hagenkord, MD, FCAP

Chief Medical Officer, 23 and Me
close
-
Dr. Jill Hagenkord is responsible for all medical affairs activities serving as the company liaison to physician, medical, genetics and research industry groups. Jill also oversees laboratory, shipping and fulfillment operations for 23andMe. Previously, Jill served as SVP of medical strategy for InVitae Corporation, a genetics information company, where her role included serving as medical director, contributing to corporate strategy, acting as commercial liaison, and leading the company's physician education programs. Jill is a board-certified molecular genetic pathologist. Prior to joining Invitae, she served as CMO and senior vice president at Complete Genomics, Inc. Her other prior experiences include founder and CMO for iKaryos Diagnostics, associate professor of pathology at Creighton University School of Medicine, director of molecular pathology and clinical genomics at Creighton Medical Laboratories, and pathologist at Deltagen, Inc. Jill received her M.D. from Stanford University School of Medicine in 1999, did her residency training in pathology at the University of California at San Francisco and the University of Iowa, and completed fellowships in pathology/oncology informatics and molecular genetic pathology at the University of Pittsburgh Medical Center.
Benjamin Heywood
arrow

Benjamin Heywood

Co-Founder and President, Patients Like Me
close
-
During its 10 year history, Ben has overseen all stages of PatientsLikeMe’s growth, including financing, the expansion of patient communities, and business partnerships. Today he defines the company's product strategy and roadmap and directs the user experience (UX) and engineering teams. Combined, these roles ensure PatientsLikeMe's website continuously evolves to meet patient needs, and that the patient voice continues to define value in healthcare. Ben also serves as the company’s Chief Privacy Officer. Ben is a frequent speaker at conferences and an expert source for media on patient issues and patient-centered care. Earlier in his career, he served in manufacturing and business development roles at Target Therapeutics, the leading designer and manufacturer of microcatheter-based products for the treatment of stroke, which was later acquired by Boston Scientific. He earned his bachelor’s degree in Mechanical Engineering from the Massachusetts Institute of Technology (MIT) and his master’s degree in Business Administration from UCLA’s Anderson Graduate School of Management
Christopher Hocevar
arrow

Christopher Hocevar

President, Cigna Pharmacy Management; President, Select Segment, Cigna Corporation
close
-
Mr. Hocevar is the president of Cigna Pharmacy Management, the company’s pharmacy benefits management business and president of Cigna's Select Segment, which focuses on benefit solutions for groups with 25-250 employees. He has led the U.S. Individual and Family Plan Segment and the Emerging Markets Segment, and served as the business merger and acquisition lead for several of Cigna's acquisitions/partnerships. Previously, he analyzed international insurance markets and risks for Deloitte Consulting. Mr. Hocevar earned his Bachelor of Business Administration in Accounting from the University of Toledo and earned his Master of Business Administration from the Weatherhead School of Management.
Jill Rubin Hummel
arrow

Jill Rubin Hummel

President and General Manager, Anthem Blue Cross and Blue Shield in Connecticut
close
-
Ms. Hummel is president of Anthem Blue Cross and Blue Shield where she is responsible for operations, including sales, underwriting, managing external relationships with key stakeholders and guiding efforts to transform healthcare. Previously, she was vice president of Payment Innovation for Anthem, Inc., where she was accountable for developing provider payment and delivery models that reward and support improvements in health care quality, patient safety and health outcomes, while reducing healthcare costs. She serves on the board and is vice chair-elect for the Patient-Centered Primary Care Collaborative, and she serves on the board of directors for the Governor’s Prevention Partnerships.
Praduman Jain
arrow

Praduman Jain

CEO, Vibrent Health
close
-
Mr. Jain is the CEO of Vibrent, which provides “consumer-centered” precision health and precision medicine solutions for personal and population health. This advanced bioinformatics learning health system delivers evidence-based, clinical and behavior change programs outside the clinic walls, using mobile phones. Mr. Jain was the founding chair of mHealth initiative of Continua Health Alliance, an open industry alliance of 240 healthcare and technology organizations driving interoperability guidelines. He has held a variety of senior leadership roles at Clearwire, Sprint, Nextel, AOL, Time Warner and VTech. Mr. Jain holds several patents and M.S., B.S. degrees in Electrical Engineering.
Steven Kafka, Ph.D.
arrow

Steven Kafka, Ph.D.

Chief Operating Officer, Foundation Medicine
close
-
Chief Operating Officer, Foundation Medicine. Dr. Kafka has over 15 years of business and strategy experience in the pharmaceutical and biotechnology industries, with a focus on \oncology. He was previously chief operating officer and chief financial officer at Aileron Therapeutics, where he led the operations, finance, and human resources functions.
Martin Kohn, M.D.
arrow

Martin Kohn, M.D.

Chief Medical Scientist, Sentrian
close
-
Dr. Martin Kohn is Chief Medical Scientist at Sentrian, winner of the 2015 Innovation in remote patient care award from the American Telemedicine Association. His research includes predictive analytics and expert systems in the clinical decision process. Dr. Kohn is a board-certified emergency physician withover 30 years of practice and management experience. He is certified in Clinical Informatics and has published multiple articles and book chapters on clinical, technical and management subjects. He was recently named one of the 16 healthcare data-driven "geeks" to watch by Healthcare IT News.
Ranga Krishnan, M.B., C.h.B.
arrow

Ranga Krishnan, M.B., C.h.B.

Professor, Neuroscience and Behavioral Disorders Program, Duke – NUS Singapore
close
-
Dr Krishnan is currently Professor of Psychiatry and Behavioral Sciences Duke University and Duke-NUS, Singapore and previously Dean of Duke-NUS Graduate Medical School, Singapore. He is Chairman National Medical Research Council Singapore. Dr Krishnan was previously Chair of Psychiatry and Behavioral Sciences at Duke from 1998 to 2009. Dr Krishnan is a member of the Institute of Medicine, National Academy of Sciences. He has received numerous awards and honors for his work including the Laughlin Fellow, American College of Psychiatry, Rafaelsen Award Collegium Internationale Neuro-Psychopharmacologicum (CINP,) Brain Behavior Research Foundation National Alliance for Research on Schizophrenia and Depression (NARSAD) Distinguished Investigator Award Depression and Bipolar Support Alliance DBSA Klerman Award, American Association for Geriatric Psychiatry. (AAGP) Distinguished Scientist Award, Charles Burlingame Award and the American College of Psychiatry Research Award in Geriatric Psychiatry. American College of Psychiatry Research Award in Mood Disorders. Dr Krishnan has conducted research primarily in the area of late life depression, Bipolar disorder and dementia. He is an authority on the use of imaging in the diagnosis and treatment of mood disorders. He is well recognized for his work establishing the interplay between vascular disease and depression. He has published over 450 articles and numerous chapters. He has also been instrumental in creating new ways to diagnose and treat mental health disorders.
Bruce T. Liang, M.D., F.A.C.C.
arrow

Bruce T. Liang, M.D., F.A.C.C.

Dean, UConn School of Medicine
close
-
Dr. Bruce T. Liang, an internationally recognized cardiologist and researcher, is the Dean of the UConn School of Medicine. He is the Director of the Pat and Jim Calhoun Cardiology Center, Chief of the Division of Cardiology and serves as the Ray Neag Distinguished Professor of Vascular Biology and Cardiology at UConn Health.Dr. Liang served as Interim Dean in 2011 and 2015 and was appointed as Dean in June 2015 by Provost Mun Choi. He is a fellow of the American College of Cardiology, the American Heart Association and the Council on Clinical Cardiology and Basic Cardiovascular Sciences. Dr. Liang is also an elected member of the American Society for Clinical Investigation, of the Association of University Cardiologists, and of the Connecticut Academy of Science and Engineering.After 13 years with the University of Pennsylvania School of Medicine where he served as an associate professor both of medicine and pharmacology and was actively involved with research, patient care and teaching, he joined the UConn Health Center in 2002.He is widely published in the areas of cell biology and pharmacology of the cardiovascular system, as well as translational research in heart failure. In research, he has been continuously funded since 1986 by the National Institutes of Health, the American Heart Association and the Department of Defense. Dr. Liang was the lead investigator of a clinical research study conducted at the UConn Health Center that identified a protein fragment that when detected in the blood can be a predictor of heart attack. The study was published in the Journal of the American College of Cardiology.Dr. Liang has been consistently named an America’s Top Doctor by Castle Connolly in cardiovascular disease since 2003, and has been recognized as a Best Doctor in America by Best Doctor, Inc. Dr. Liang received his medical degree from Harvard Medical School. He completed his residency at the Hospital of the University of Pennsylvania, and cardiology fellowship at Brigham and Women’s Hospital and Harvard Medical School.
Andrew Lo, Ph.D.
arrow

Andrew Lo, Ph.D.

Professor of Finance, and Director, Laboratory for Financial Engineering, MIT Sloan School of Management
close
-
Dr. Lo's research interests include the empirical validation and implementation of financial asset pricing models; hedge-fund risk and return dynamics and risk transparency; and, most recently, evolutionary and neurobiological models of individual risk preferences and financial markets.
Christopher Loose, Ph.D.
arrow

Christopher Loose, Ph.D.

Assistant Professor of Urology, Lecturer in Biomedical Engineering and Executive Director of CBIT, Yale University
close
-
Dr. Loose serves as executive director of the Yale Center for Biomedical and Interventional Technology. He is also an Accelerator executive at the Center for Integration of Medicine and Innovative Technology (CIMIT). While earning his Ph.D. in Chemical Engineering at MIT, Dr. Loose co-founded Semprus Biosciences and served as CTO through its acquisition and FDA approval of an anti-clotting vascular catheter. Prior to his graduate work, Dr. Loose was a chemical engineer at Merck Research Labs after graduating summa cum laude with a B.S.E. in Chemical Engineering from Princeton University.
John MacPhee, MPH, MBA
arrow

John MacPhee, MPH, MBA

CEO, JED Foundation
close
-
John MacPhee serves as CEO of The JED Foundation, a non-profit that exists to promote emotional health and prevent suicide among teens and young adults. Prior JED, he served as president of Strativa Pharmaceuticals, where he oversaw commercial operations, clinical development, medical affairs and business development. Previously, he worked at Forest Laboratories, where he led the launches of treatments for depression, anxiety and Alzheimer's disease. John also serves as a board member of Adamas Pharmaceuticals, BlackThorn Therapeutics, and as an advisor to several charities. He earned a BA and MPH from Columbia University, and an MBA from New York University.
Brendan Maher
arrow

Brendan Maher

Associate Professor of Law and Robert D. Paul Scholar, UConn School of Law
close
-
Professor Maher is a professor of Law and the director of UConn's independently endowed Insurance Law Center. A graduate of Stanford University and Harvard Law School, Professor Maher is a nationally recognized expert in the regulation of insurance, pensions and healthcare. He is a leading authority on the meaning of both ERISA and the Affordable Care Act. He routinely appears before the United States Supreme Court to litigate cases involving ERISA, the federal statute governing employee benefits.
Lawrence J. Markson, MD, MPH
arrow

Lawrence J. Markson, MD, MPH

CMIO and Vice President, Clinical Information Systems
close
-
Dr. Markson is the chief medical information officer and vice president for Clinical Information Systems at Beth Israel Deaconess Medical Center (BIDMC). Dr. Markson oversees all of the hospital’s clinical systems, including its web-based electronic health record, its personal health record, its healthcare information exchange, and its data warehousing and analytics operations. BIDMC has a long history of clinical IT innovation, was the first hospital in the country to achieve meaningful use, and was one of the first hospitals to invite patients to view provider visit notes through its patient portal.
David McCallie Jr., M.D.
arrow

David McCallie Jr., M.D.

Senior Vice President, Medical Informatics, Cerner Corporation
close
-
Dr. David McCallie, senior vice president, Medical Informatics, is director of the Cerner Medical Informatics Institute. He is responsible for a research and development team focused on developing innovations at the intersection of computer science and clinical medicine. His most recently completed project was the design of Cerner’s ePrescribing system and the Community Health Record. He is currently working on the definition of the next generation of personal health records, known as Independent Health Record Trusts.Dr. McCallie joined Cerner in 1991. He was previously responsible for the development of Cerner’s clinical nomenclature system and the PowerNote™ structured clinical documentation tool. He also was the chief architect for open clinical foundation, Cerner’s clinical data repository. He is a member of Cerner’s architecture cabinet.Prior to joining Cerner, McCallie was director of research computing at Children’s Hospital in Boston, Mass., and an instructor in neurology at Children’s Hospital and Harvard Medical School. His research background includes using computers to create three-dimensional models of seizure-induced brain electrical activity.McCallie earned a bachelor’s degree in electrical engineering and computer science at Duke University. He earned his medical degree at Harvard Medical School. McCallie has published numerous articles and presented frequently on the subject of healthcare informatics. He is a member of the American Medical Informatics Association.
Gregory Moore, M.D., Ph.D.
arrow

Gregory Moore, M.D., Ph.D.

Chief Emerging Technology Officer, Geisinger Health System
close
-
Dr. Moore serves as chief emerging technology and informatics officer for Geisinger Health System and director of Geisinger’s Institute for Advanced Application. Dr. Moore continues to practice as a diagnostic neuroradiologist and maintains an active research program as an Abigail Geisinger clinician investigator. Dr. Moore served as vice chair of Radiology for Geisinger Health System. He held appointments at Los Alamos National Laboratory, Wayne State University School of Medicine and at Penn State University where he was a tenured professor in the College of Medicine. Dr. Moore received his Ph.D. from the Massachusetts Institute of Technology (MIT) and his M.D. at Wayne State University School of Medicine followed by residency training at Penn State University College of Medicine.
Kush Parmar, MD, PhD
arrow

Kush Parmar, MD, PhD

Partner, 5AM Ventures
close
-
Dr. Parmar is a Partner at 5AM Ventures. He joined 5AM from Harvard Medical School, where he was an NIH-sponsored M.D./PhD Physician Scientist Fellow in the joint Harvard-MIT Health Sciences and Technology Program. Dr. Parmar currently serves as a Director or Observer on the Boards of Arvinas, Audentes, Novira, Pulmatrix and scPharmaceuticals. He previously served as Board Observer for Achaogen (NASDAQ: AKAO) and Envoy (acquired by Takeda). He is a Fellow of the Society of Kauffman Fellows. Dr. Parmar is a member of the Scientific Advisory Council of Princeton University's Department of Molecular Biology and the Grace Wilsey Foundation. He also founded a non-profit international development organization, the Cruz Blanca Initiative. He holds an A.B. in Molecular Biology and Medieval Studies from Princeton University, a PhD in Experimental Pathology from Harvard University, and an M.D. from Harvard Medical School. Dr. Parmar is based in Boston.
Steven Quake, Ph.D.
arrow

Steven Quake, Ph.D.

Stanford University Professor of Bioengineering and Applied Physics, and Investigator, Howard Hughes Medical Institute
close
-
Dr. Quake has founded or co-founded several companies, including Fluidigm, Helicos Biosciences, Verinata Health, Quanticel Pharmaceuticals, Moleculo, Cellular Research and Immumetrix.
Jack Reed
arrow

Jack Reed

President and CEO, ProHealth Physicians
close
-
Jack Reed is the President and Chief Executive Officer of ProHealth Physicians, Inc., one of the largest primary care systems in the Northeast. He has extensive experience in the development, implementation and management of health related businesses including those in managed care and provider/hospital networks. Prior to his role at ProHealth Physicians, Mr. Reed was a founder and President/CEO of HealthDIRECT, Inc., a managed care company that provides systems and services for workers compensation and disability carriers. He was the former President/CEO of the VHA of Southern New England, a regional health care network organized by twelve Connecticut hospitals. The VHA of Southern New England was responsible for the development of health-related companies and programs for managed care services, home infusion therapy, disability management and other hospital management and ancillary services. In this capacity, Mr. Reed facilitated and chaired the development of a statewide HMO, which was later acquired by Aetna Health Plans. Mr. Reed was formerly an executive for the Detroit Medical Center. At the DMC, he held several positions in administration and within their for-profit subsidiary, Radius Health Care. While working with Radius, he had a key role in the acquisition, operation and/or integration of a series of health care services including multi and single specialty group practices, physician offices, nursing homes, home health care and management service programs. Mr. Reed holds an MBA from Rensselaer Polytechnic Institute, Troy, New York and a BS in Economics from Siena College, Loudonville, New York.
Mostafa Ronaghi, Ph.D.
arrow

Mostafa Ronaghi, Ph.D.

Chief Technology Officer and Senior Vice President, Illumina
close
-
Dr. Ronaghi is senior vice president and chief technology officer at Illumina; he is responsible for leading internal research and the Illumina accelerator program. He co-founded Avantome, a privately held sequencing company and NextBio, a search engine for life science data, among others. He was a principal investigator at Stanford University. He serves on the board of directors of Aurora Algae and BaseHealth. He earned his Ph.D. from the Royal Institute of Technology in Sweden. He holds more than 30 (pending and issued) patents and has written more than 70 peer-reviewed publications in journals and books.
Juan C. Salazar, M.D., M.P.H., F.A.A.P.
arrow

Juan C. Salazar, M.D., M.P.H., F.A.A.P.

Physician-in-Chief, Connecticut Children's Medical Center
close
-
Dr. Salazar is the chair of the Department of Pediatrics at the University of Connecticut School of Medicine and physician-in-chief at Connecticut Children’s Medical Center. In addition to these roles, Dr. Salazar is a professor of Pediatrics and Immunology and division head of Pediatric Infectious Diseases, and director of the Pediatric and Youth HIV Program at Connecticut Children’s.
Richard Salmon, M.D., Ph.D.
arrow

Richard Salmon, M.D., Ph.D.

Vice President and National Medical Executive for Performance Measurement and Improvement. Cigna
close
-
Dr. Salmon is vice president and national medical executive for Performance Measurement and Improvement at Cigna. He has held several other positions at Cigna. Previously, he was senior vice president and chief medical officer for the HMO HealthSource. He was assistant professor of family medicine and chief resident in family practice at Case Western Reserve University and its affiliated University Hospital. He is board-certified in family practice and earned his medical degree and Ph.D. in biomedical engineering from Case Western Reserve University. He holds a Bachelor of Science degree in engineering and a Bachelor of Arts degree from Princeton University.
David Shaywitz, M.D., Ph.D.
arrow

David Shaywitz, M.D., Ph.D.

Chief Medical Officer, DNAnexus
close
-
Dr. Shaywitz is chief medical officer at DNAnexus, and holds an adjunct appointment as Visiting Scientist in the Department of Biomedical Informatics at Harvard Medical School. He has a decade of experience in the life science industry, with experience in R&D, strategy, and commercial operations through his work at Merck, the Boston Consulting Group, and Theravance. Dr. Shaywitz received his MD/PhD from Harvard and MIT, and trained in internal medicine and endocrinology at the Massachusetts General Hospital. He is co-author, with Lisa Suennen, of "Tech Tonics: Can Passionate Entrepreneurs Heal Healthcare With Technology?", and co-host, with Lisa Suennen, of "Tech Tonics," a twice-a-month podcast focused on the people and passion at the intersection of technology and health, and available on iTunes.
Catherine Smith
arrow

Catherine Smith

Commissioner, Department of Economic and Community Development
close
-
Catherine Smith is the Commissioner of the Connecticut Department of Economic and Community Development (DECD), the lead state agency responsible for attracting and retaining businesses and jobs, revitalizing neighborhoods and communities, and fostering appropriate development in Connecticut’s towns and cities. Governor Dannel P. Malloy appointed her to the position in April 2011. Commissioner Smith’s top economic development priorities are to strengthen the state’s efforts to nurture and drive innovation; effectively promote and market the state’s many business advantages within Connecticut and beyond its borders; and place a renewed emphasis on all aspects of customer service in order to make the state more business-friendly and attractive for investment. Her community development priorities include improving the state’s ability to redevelop brownfields, continuing the state’s commitment to responsible growth and transit-oriented development and fostering arts and culture to make our cities more vibrant and attractive. The commissioner is forging closer working relationships with private sector partners to realize these objectives and to maximize the return on state investments. Prior to joining DECD, Commissioner Smith had a distinguished career in the insurance and financial services industry. She began her career at Aetna in 1983 and held various management positions, including investment officer and chief financial officer for Aetna Financial Services. Later at ING she served in numerous leadership positions including chief operating officer for ING U.S. Financial Services, and CEO of the U.S. Insurance businesses. In 2008 Smith was named CEO of ING U.S. Retirement Services, one of the largest defined contribution plan managers in the United States with more than $280 billion in assets under management and administration. Smith graduated from Hampshire College in Amherst, Massachusetts, and received a Master’s degree in public and private management from the Yale School of Management in New Haven, Connecticut. Smith has been a frequent speaker at industry conferences and in the media and has been recognized by U.S. Banker magazine’s “Top 25 Most Powerful Nonbank Women in Finance”. Smith is a board member of Outward Bound, USA.
Michael Sturmer
arrow

Michael Sturmer

Vice President, Consumer Engagement, Cigna
close
-
As vice president for Consumer Health Engagement, Mr. Sturmer is responsible for development and implementation of a Consumer Health Engagement Strategy focused on redefining how consumers engage with their health, Cigna and the broader health ecosystem. Over the course of his career, he has held various leadership roles within IT. He represents Cigna in the Northeast Business Group on Health payer and provider collaborative and is part of the IHI Collaborative focused on innovation to drive better health and lower cost for patients with complex needs. He holds an associate’s degree in Nursing and a bachelor’s degree in Health Administration.
Allen Tien, MD, MHS
arrow

Allen Tien, MD, MHS

Founder, President, and Director of Applied Research of Medical Decision Logic, Inc. (“mdlogix”)
close
-
Dr. Tien is Founder, President, and Director of Applied Research of Medical Decision Logic, Inc. (“mdlogix”). As well as being a Board-Certified psychiatrist, he has Master's level training in biostatistics and postdoctoral training in psychiatric epidemiology, research design and methods, and public mental health issues. Dr. Tien was a full-time tenure-track faculty member in the Johns Hopkins University School of Public Health Department of Mental Hygiene and School of Medicine Department of Psychiatry from 1988 to 1997, promoted to Associate Professor in 1996. Active in research in public mental health epidemiology, services, and prevention, and clinical neuroscience, for a number of years he taught a key Mental Hygiene course on multi-level etiologic models of mental disorders. He has been developing both software and hardware for computer-based assessment systems since 1987, and is knowledgeable about information technology design and engineering. He conceived of and continues to lead a number of Small Business Innovation Research (SBIR) projects that address psychometrics and the assessment of symptoms, diagnostic and treatment logic, indexed audio and video recording and playback, data management, graph (e.g., social networks, genetic networks) visualization, software tools for social network analysis (SNA), multi-level integration of genetic and phenotype data, nursing workflow, patient education, primary care behavioral health screening, and patient reported outcomes for palliative and hospice care. He provided the vision and leadership at mdlogix for the development of the Health Science Process Framework (HSPF). A major result is the mdlogix Clinical Research Management System (CRMS), a proven enterprise-scale integrated web solution for unlimited multi-site study protocols, multi-role team workflows, study level data collection, reporting, management, and analysis, integrated financial management, and compliance and institutional monitoring and reporting. Furthermore, Dr. Tien has led the vision for and use of CRMS-HSPF as the translational platform for clinical care and public health projects and programs, the flourishing example being www.BH-Works.com, a solution for validated comprehensive assessment of patients for depression, alcohol, and other behavioral health risks and mental illness problems, currently being used and expanded across eight states. Dr. Tien also led the creation of the www.SocioWorks.com system for the efficient application of social network science methods.
Brad Tritle
arrow

Brad Tritle

President and CEO, Vitaphone
close
-
Mr. Tritle serves as president/CEO for vitaphone e-health solutions, an international, mobile telehealth and patient engagement firm. He is co-author of the HIMSS book Engage! Transforming Healthcare through Digital Patient Engagement, and has chaired both the HIMSS Patient Generated Health Data and Healthcare Social Media task forces. Prior to vitaphone, he served as a health IT consultant to HHS, for-profit companies and non-profit organizations. His past positions include serving as CEO of eHealthTrust, executive director of Arizona Health-e Connection, and in other corporate and government leadership. Mr. Tritle is a Certified Information Privacy Professional (CIPP/US).
Rick Weisblatt, Ph.D.
arrow

Rick Weisblatt, Ph.D.

Chief of Innovation and Strategy, Harvard Pilgrim Health Care
close
-
Dr. Rick Weisblatt is Chief of Innovation and Strategy for Harvard Pilgrim Health Care, New England’s leading not-for profit health plan. Dr. Weisblatt is responsible for actively identifying and assessing new innovation opportunities based on emerging trends. He leads the development and monitoring of Harvard Pilgrim’s long term strategic plan. Dr. Weisblatt also directs the Harvard Pilgrim provider strategy and recently implemented new risk arrangements intended to align the interests of physicians, health plans and patients. Dr. Weisblatt led the development of new network products including limited and tiered designs, health engagement incentive programs, transparency tools and member steerage programs. More recently, he has led efforts to deepen Harvard Pilgrim’s provider relationships including a joint venture with major health care systems in New Hampshire which features new models for collaborative population health management.Dr. Weisblatt is a frequent speaker and trusted adviser to policy makers, regulators and elected officials on such subjects as health care reform, behavioral health, market competition and health care cost trends.Dr. Weisblatt has a doctorate in clinical psychology from the University of Maryland and his clinical interests have been in treating children, adolescents and couples. Founded in 1969, Harvard Pilgrim and its affiliates are licensed to provide comprehensive health insurance solutions in Massachusetts, Maine, New Hampshire and Connecticut. Its provider network has more than 32,000 physicians and 150 hospitals. Harvard Pilgrim and its affiliates offer health and benefit plan solutions to over 1 million members in New England. It was awarded NCQA’s Number One Health Plan in the nation ten years in a row.